That means it activates three different receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
If youre considering starting or switching medications, it helps to understand the differences between common options
A few years ago, almost nobody outside an endocrinologists office could pronounce semaglutide. Today it feels like every other conversation circles back to it
This is likely why retatrutides triple agonism works so well: it captures glucagons metabolic and lipid effects without causing high blood sugar
However, given the similar clinical efficacy and safety profiles amongst the available agents within the DPP-4 class of medications, the published head-to-head trials reviewed in this manuscript represent a good comparison of the two classes of medications (26, 35)
Researchers have proposed several mechanisms for the KD effect on weight loss including: (1) reduced appetite due to the higher satiety effect of proteins (by increasing the concentrations of satiety hormones, such as glucagon-like peptide-1, cholecystokinin, and ghrelin), 119,120 effect on appetite-control hormones, 121 and a possible direct suppression of appetite by KBs, such as -HB, which act both in energy/satiety signaling and in mediating the central satiety signal